Artificial Intelligence (AI) and emerging technologies are rapidly advancing, influencing every aspect of business operations, including the biotechnology and life sciences sectors.
SeerPharma has partnered with students from The University of Melbourne's Master of Biotechnology program to conduct a comprehensive survey of the industry and develop scenarios and prototypes that demonstrate the potential uses of these technologies.
This project aims to explore the application of these technologies in both training and competency assessment within these industries.
The students will create practical examples of company processes requiring training and assessment, utilising the following technologies:
The students have begun engaging with SeerPharma's clients and connections in the industry. This collaboration aims to produce a detailed report on the impact of AI and emerging technologies on training in the pharmaceutical and medical device industries. The report, which will be published later this year, will offer valuable insights to industry professionals on how to stay agile in the face of technological advancements and evolving work practices. It will also serve as a key resource for Quality Assurance and GMP professionals.
Our partnerships with leading universities across the APAC region, including the University of Melbourne, University of Technology Sydney, Chinese University of Hong Kong, and National University of Singapore, along with our dedication to staying at the forefront of emerging trends in Quality and GMP training, are essential to our mission of advancing best practices in Quality and GMP throughout the region.
Contact us if you would like to learn more about this study and the technologies being investigated.